-->

Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesApr 2, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 26, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 26, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 26, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 26, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 20, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 20, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 20, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 18, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 18, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 18, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 18, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 10, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 10, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 10, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 10, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 7, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 7, 2008View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Mar 5, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 4, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 4, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 4, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 4, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 4, 2008View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 4, 2008View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-125      126-150      151-152

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information